Robuta

Ribociclib plus endocrine therapy demonstrates a reduction in the risk of disease recurrence in patients with HR+/HER2- early breast cancer.

The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians engage in shared, informed decision making with women who are at increased risk of...

Astellas Pharma Inc. announced that data from a Phase 2 study evaluating the investigational use of enzalutamide as a single agent for the treatment of...

This easy-to-read booklet is about being diagnosed with primary breast cancer and deciding on what treatment is best for you.

Breast cancer is the most common non-dermatologic cancer in women across all races in the United States. Women with prior or current breast cancer

Find out about the different types of surgery for primary breast cancer, including breast-conserving surgery or lumpectomy, mastectomy and breast reconstruction

BRCA1/2 carriers exhibit a 2- to 3-fold higher risk of second primary cancer than non-carriers. Ovarian cancer represents the majority of second primary...

This booklet describes the treatments available to people with invasive primary breast cancer. It describes treatment decisions and finding support.